Brain tumors are the deadliest form of childhood cancer. Although survival rates for some pediatric brain tumors have increased over the past few decades, current treatment options including radiation and chemotherapy are often quite toxic, causing children to often suffer from long-term side effects.
Investigators at Nationwide Children’s Hospital are focused on developing treatment strategies for children with brain tumors that not only treat disease, but ensure improved quality of life.
Virotherapy Shows Promise Against Highly Malignant Pediatric Tumors
Adam Studebaker, PhD, research scientist in the Center for Childhood Cancer and Blood Diseases at The Research Institute at Nationwide Children’s, is lead author of a recent Neuro-Oncology paper that shows a modified measles virus is an effective therapeutic agent against a type of tumor that does not respond well to chemotherapy and primarily affects children under 3 years of age